b'PROOF-OF-CONCEPT GRANT RECIPIENTSResearchers developing breakthroughs into life-saving treatments receive up to $150,000 to accelerate promising research and pursue commercialization opportunities with the private sector. COLORADO SCHOOL OF MINES UNIVERSITY OF COLORADO BOULDERAndrew Petruska, Ph.D.Steadiplay,Linda Watkins, Ph.D.Individualized a balance screening and interactivetreatment for multiple sclerosis training system for balance therapy.through site-specific drug therapy.COLORADO STATE UNIVERSITY UNIVERSITY OF COLORADO John Mizia, M.S.Wavelength-specific,ANSCHUTZ MEDICAL CAMPUSnarrowband LED photochemicalNicholas Jacobson, MDesS3D printed vaccine manufacturing testbed. nasoalveolar molding devices for the presurgical treatment of cleft palate. Vivian Li, Ph.D.Developing cellu-lose nanocrystals to convert hempUNIVERSITY OF DENVERagrowaste to high-value bioproducts.Ali Azadani, Ph.D.Left atrium unloading device for the treatment of heart failure with preserved ejection fraction. CONTACT:Michael Ehrman303.487.4260michael.ehrman@mittera.comSpecializing in print communications for the BioScience and Pharmaceutical community, Mittera is one of the countrys leading providers of print, mail and marketing services. With Mittera, youre guaranteed access to a community of knowledgeable professionals who prioritize cutting-edgetechnology, quality and efficiency with every job. With a manufacturing platform of award-winning printingoperations across the United States, we can maximizemittera.comany project from short-run market-specificversions to high-volume mailings.MITTERA GROUP COMPANY2023-2024 BIOSCIENCE COLORADO 45'